nivimedone has been researched along with Asthma, Bronchial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browne, JT; Smyth, WF | 1 |
| Kay, AB; Lumb, EM; McHardy, GJ | 1 |
| Lamont, H; Pauwels, R; Van der Straeten, M | 1 |
2 trial(s) available for nivimedone and Asthma, Bronchial
| Article | Year |
|---|---|
The orally administered anti-allergic agent, sodium nivimedone (BRL 10833); efficacy in bronchial asthma and effects on IgE, complement and eosinophils.
Topics: Administration, Oral; Adolescent; Adult; Asthma; Clinical Trials as Topic; Complement System Proteins; Eosinophils; Female; Histamine Antagonists; Humans; Immunoglobulin E; Indans; Indenes; Leukocyte Count; Male; Maximal Expiratory Flow Rate | 1979 |
The protective effect of inhaled BRL 10833 on allergen induced bronchospasm.
Topics: Adolescent; Adult; Aerosols; Airway Resistance; Allergens; Asthma; Bronchial Spasm; Cromolyn Sodium; Forced Expiratory Volume; Humans; Indans; Indenes; Male; Respiratory Hypersensitivity | 1976 |
1 other study(ies) available for nivimedone and Asthma, Bronchial
| Article | Year |
|---|---|
Polarographic behaviour and analysis of 2-nitro-5,6-dimethylindane-1,3-dione in raw materials and pharmaceutical formulations.
Topics: Asthma; Capsules; Indans; Indenes; Polarography; Tablets | 1980 |